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ABSTRACT All fully sequenced strains of Streptococcus pneumoniae possess a version of the blp locus, which is responsible for
bacteriocinproductionandimmunity.Activationofthe blplocusisstimulatedbyaccumulationofthepeptidepheromone,
BlpC,followingitssecretionbytheABCtransporter,BlpA.The blplocusischaracterizedbysigniﬁcantdiversityin blpCtype
andintheregionofthelocuscontainingputativebacteriocinandimmunitygenes.Inaddition,the blpAgenecanrepresenta
singlelargeopenreadingframeorbedividedintoseveralsmallerfragmentsduetothepresenceofframeshiftmutations.Inthis
study,weuseacollectionofstrainswith blp-dependentinhibitionandimmunitytodeﬁnethegeneticchangesthatbringabout
phenotypicdifferencesinbacteriocinproductionorimmunity.Wedemonstratethatalterationsin blpA,blpC,andbacteriocin/
immunitycontentlikelyplayanimportantroleincompetitiveinteractionsbetweenpneumococcalstrains.Importantly,strains
withahighlyconservedframeshiftmutationin blpAareunabletosecretebacteriocinsorBlpC,butretaintheabilitytorespond
toexogenouspeptidepheromoneproducedbycocolonizingstrains,stimulating blp-mediatedimmunity.These“cheater”
strainscanonlycoexistwithbacteriocin-producingstrainsthatsecretetheircognateBlpCandsharethesameimmunitypro-
teins.Thevariableoutcomeoftheseinteractionshelpstoexplaintheheterogeneityofthe blppheromone,bacteriocin,andim-
munityproteincontent.
IMPORTANCE Streptococcus pneumoniae resides in a polymicrobial environment and competes for limited resources by the elab-
oration of small antimicrobial peptides called bacteriocins. A conserved cluster of genes in the S. pneumoniae genome is in-
volvedintheproductionofbacteriocinsandtheirassociatedprotectiveimmunityproteinsthroughsecretionofasignaling
pheromone.Inthisstudy,weshowthatasigniﬁcantnumberofstrainshavelosttheabilitytosecretebacteriocinsandsignaling
pheromonesduetoaspeciﬁcmutationinadedicatedtransporterprotein.Becausetheregulatoryandimmunityportionofthe
locusisretained,these“cheater”strainscansurviveinthefaceofinvasionfromabacteriocin-producingstrainwithoutthecost
ofbacteriocinsecretion.Theoutcomeofsuchinteractionsdependsoneachstrain’srepertoireofpheromone,immunityprotein,
andbacteriocingenes,suchthatintrastraincompetitiondrivesthediversityinbacteriocin,immunityprotein,andpheromone
content.
Received 5 August 2011 Accepted 17 August 2011 Published 6 September 2011
Citation Son MR, et al. 2011. Conserved mutations in the pneumococcal bacteriocin transporter gene, blpA, result in a complex population consisting of producers and
cheaters. mBio 2(5):e00179-11. doi:10.1128/mBio.00179-11.
Editor Larry McDaniel, University of Mississippi Medical Center
Copyright © 2011 Son et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License,
which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Jeffrey N. Weiser, weiser@mail.med.upenn.edu
S
treptococcus pneumoniae (the pneumococcus) is a leading
causeofbacteremia,meningitis,pneumonia,andotitismedia.
The majority of young children are colonized with this organism
at some point during their toddler years. Nasopharyngeal coloni-
zation is largely asymptomatic but is a prerequisite for the devel-
opmentofinvasivedisease.Inordertosurvivewithinthepolymi-
crobialenvironmentofthenasopharynx,thepneumococcusmust
compete with the endogenous ﬂora, including other pneumo-
cocci. The prevalence of colonization in young children is high,
andsimultaneouscarriageofmorethanasinglestrainiscommon.
Inaddition,S.pneumoniaeisoneofagroupofrelatedstreptococci
colonizing the human upper respiratory tract. It is, therefore, not
surprisingthatthereiscompetitionamongpneumococciandpos-
sibly between pneumococci and other oral streptococcal species.
The blp-encoded bacteriocins have been shown to contribute
tointraspeciescompetitioninamurinemodelofcolonization(1).
Sequence analysis has demonstrated that the locus is heteroge-
neous, with the potential to produce a wide array of bacteriocins
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that encode a typical three-component regulatory system (blp-
CRH) and an ABC transporter (blpAB), as well as conserved pro-
teins that may contribute to bacteriocin immunity (BlpYZ and
SPO547) (Fig. 1A) (1–3). The peptide pheromone, BlpC, is pro-
duced with a typical leader peptide linked to a double-glycine
motif.Theprepeptideiscleavedandtransportedoutofthecellvia
BlpAB (4). When levels of BlpC are sufﬁciently high, the phero-
mone triggers activation of the histidine kinase BlpH, resulting in
activation of the response regulator BlpR (5). BlpR binding has
beenshowntoresultintheupregulationoftheentireblplocus(3).
The region of the locus between blpA and bplY contains genes
predicted to encode a variable array of bacteriocin-like peptides
and bacteriocin-speciﬁc immunity proteins; we refer to this re-
gion as the “bacteriocin immunity region” (BIR) (Fig. 1A). The
bacteriocin-like peptides in this region are identiﬁed by a con-
served N-terminal leader sequence followed by a double-glycine
motif and are typically cotranscribed with speciﬁc immunity pro-
teins. From the sequences available, there are at least 11 distinct
putativebacteriocinpeptides,andseveralofthesehaveallelicvari-
ability. Speciﬁc inhibitory activity has only been experimentally
attributed to one subset of the potential bacteriocins, namely,
those encoded by speciﬁc alleles of blpMN (1). In addition to the
variability in the BIR, sequence analysis of the available genomes
has demonstrated that there are at least four distinct alleles of the
geneencodingthepeptidepheromone,blpC(3,6).Severalstudies
have shown that many strains with apparently intact blp loci lack
any appreciable inhibitory activity in vitro, suggesting additional
levels of regulation may prevent energetically costly bacteriocin
secretion (1, 2, 7). In this work, we demonstrate that interruption
oftheblpAopenreadingframe(ORF)byawidelyconserved4-bp
insertion results in strains that are unable to secrete peptide pher-
omone or bacteriocin peptides. These strains, which make up a
signiﬁcant portion of the pneumococcal population, retain the
ability to sense exogenous pheromone and thereby initiate pro-
duction of immunity proteins. The interplay between bacteriocin
producers and these “cheater” strains results in selective pressure
on the BIR to alter bacteriocin and immunity content and the
blpC-blpHpairtoalterboththebroadcastsignallimitingcrosstalk
and the sensor improving detection. These ﬁndings explain the
enormous diversity of pheromone-functional peptide combina-
tions.
RESULTS
Characterization of the blp locus from an inhibitory strain,
P133. In an attempt to identify novel bacteriocin activity, we
screenedalargenumberofpneumococcalisolatesfortheirability
to inhibit the prototypic BlpMN producer, strain 6A, in plate
overlay assays. We identiﬁed P133 as an inhibitory strain that
produced a clear zone of inhibition when tested against strain 6A
andthefullysequencedstrainTIGR4(Fig.1B).DeletionofblpRH
in P133 resulted in loss of inhibition, suggesting that the inhibi-
tory activity requires a functional blp locus (Fig. 1B). To further
clarify the dependence of inhibition on the blp locus, the locus of
P133 was moved into a heterologous type 19A background. This
strain gained inhibitory activity, demonstrating that the locus is
both necessary and sufﬁcient for the inhibitory activity of P133
(Fig. 1B). Sequence analysis of the BIR of P133 demonstrated sig-
niﬁcanthomologytotheBIRofthefullysequencedTIGR4strain,
containing the putative bacteriocin gene clusters blpIJK and
blpMNO (Fig. 1A).
Characterizationoftheblplocusofastrainwithimmunityto
P133. We identiﬁed a strain, P174, that had immunity to the in-
hibitory activity of P133 but lacked any blp-dependent inhibition
(Fig. 1B) (data not shown). We used an approach similar to that
used with the P133 locus to conﬁrm that P174 immunity was blp
dependent by examining the immunity of both a blp deletion in
P174 (P174blp) and a 19A strain containing the P174 locus
(19Ablp174). P174blp lost immunity to P133, while 19Ablp174
gained immunity to P133 in overlay assays compared with the
original 19A strain, P690 (Fig. 1B), demonstrating that immunity
to the P133 elaborated bacteriocins requires the P174 blp locus.
The content of the BIR was examined by comparing restriction
proﬁles of P174 with those of P133 and TIGR4. The restriction
proﬁles of the three strains were identical, suggesting similar bac-
teriocin/immunityproteincontents(seeFig.S1inthesupplemen-
talmaterial).ThepresenceofasimilarBIRtoP133combinedwith
the lack of blp-dependent inhibition suggested that P174 lacks a
functional bacteriocin/pheromone secretion system. Analysis of
the blpA and blpC genes from P133 and P174 demonstrated that
the pair had identical BlpC types, but their blpA genes differed
with respect to a 4-bp repeat insertion in the transporter gene,
blpA, found only in P174. This insertion results in a frameshift
mutation that disrupts the single open reading frame of blpA
(Fig. 2A). The repeat has been identiﬁed in the blpA sequence of a
FIG 1 Model for blp locus activation and demonstration of the inhibitory
phenotype of isolate P133. (A) Diagrammatic representation of the blp locus
showing the location of the BIR between the conserved genes blpA and blpY.
The genomic organization of the P133/TIGR4 BIR is shown as an example.
Under low-density conditions, BlpC is secreted at a low basal levels by the
BlpAB complex. When local BlpC concentrations are sufﬁciently high, BlpC
bindingtoBlpHresultsinactivationoftheresponseregulatorBlpR.Activated
BlpRupregulatestheproductionofblptranscriptsatthesitesmarkedbydou-
blearrows.Activationofthelocusresultsinproductionofimmunityproteins
and accumulation of prebacteriocin, which is processed and secreted by
BlpAB.Putativebacteriocinsareshowninyellow,putativebacteriocin-speciﬁc
immunity proteins are shown in brown, the ABC transporter is shown in
green, the regulatory proteins are shown in gray, and BlpC is shown in blue.
Genes of unknown signiﬁcance are shown in white. Genes with existing blp
annotationarelabeled.(B)Isolatesweretestedforinhibition(spikedstrain)or
immunity(overlaystrain)usingoverlayassays.Zonesofclearingsurrounding
the spiked isolate signify inhibition.
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but its signiﬁcance was unknown.
Characterization of the role of the 4-bp repeat in regulation
oftheactivityoftheblplocus.Tofurtherexaminethecorrelation
between the presence of an intact blpA gene and the ability to
secrete Blp bacteriocins, we constructed an integration plasmid
containing700bpofP133blpsequencethatwasdesignedtoboth
repair the 4-bp insertion in the P174 blpA gene and function as a
reporter for blp transcriptional activity by taking advantage of the
proximity of the divergent promoters driving blpI and blpA to the
4-bprepeatregion(Fig.2B).TheresultantP174transformantsfell
into one of two phenotypes when plated on X-Gal (5-bromo-4-
chloro-3-indolyl--D-galactopyranoside)-containing media, de-
pending on the site of integration of the plasmid. When plasmid
integrationoccurredupstreamoftherepeat,resultinginanintact
blpA ORF, the strains had endogenous responsiveness to their
own BlpC secretion (P174on-repaired). Plasmid integration down-
stream of the repeat (P174off) resulted in strains that were only
transcriptionally active when BlpCR6 peptide was added exoge-
nously to the media (Fig. 2C). P133 was able to induce transcrip-
tion of the blp locus in the P174off strain when tested in overlay
media containing X-Gal, demonstrating transcriptional response
to P133-secreted pheromone (Fig. 2D). To further demonstrate
the dependence of P174 immunity on BlpCR6 secretion, a chime-
ricstrain,19Ablp133C6A,wascreatedinwhichP133BIRtranscrip-
tion was driven by a Blp6A regulatory region, which is of a distinct
pherotype(Fig.2E).Unliketheoriginal19Ablp133strain(Fig.2F),
19Ablp133C6A was able to inhibit the growth of 19Ablp174
(Fig.2G),verifyingthatP174immunityisactivatedbyBlpCR6that
is secreted by P133. As further conﬁrmation of the importance of
an intact blpA gene, repair of the repeat in P174 (P174on) resulted
in a strain with inhibitory activity when tested in overlay assays
(Fig. 2H). These ﬁndings conﬁrm that the presence of the frame-
shiftmutationresultsinastrainthatcanonlyturnontheblplocus
in response to exogenous peptide pheromone. Remote activation
provides immunity but not inhibitory activity because the defect
in the ABC transporter prevents secretion of both BlpC pher-
emone and bacteriocin.
Demonstrationofthecheaterphenotypeinvivo.Todemon-
strate that the in vitro interactions that we have observed between
bacteriocin-sensitive, producer and immune strains are relevant
on mucosal surfaces, we examined the interactions between oth-
erwise isogenic strains with these three phenotypes in a mouse
modelofcolonization.Thetype19AstrainwiththeP133blplocus
FIG2 CorrectionoftheAAGCrepeatinP174resultsinactivetranscriptionoftheblplocusandrecoveryofinhibitoryactivity.(A)Demonstrationoftheeffect
of the 4-bp repeat on the blpA ORF. The sequence starts at nt 433 from the blpA start codon for the predicted translated product. The 4-bp repeat sequence is
underlined. Amino acids highlighted in light gray are found in the intact BlpA product; dark gray amino acids are found only in the disrupted BlpA protein.
Predicted new stop and start codons resulting from the frameshift mutation are marked by boxes. (B) Diagramatic representation of construction of theo na n d
off reporter strains in P174. P174 transformed with pE65 was selected on kanamycin to recover strains with plasmid integration. pE65 has the 5= region of the
non-repeat-containingblpAgenefromP133followedbydivergentpromotersdrivingblpA(PA)andblpItranscription(PI).PIdriveslacZexpression.Integration
at point 1 results in repair of the disrupted blpA ORF in P174, while integration at point 2 results in retention of the disrupted blpA gene. Promoters are shown
with solid arrows signifying the direction of transcription. (C) Phenotypic conﬁrmation of P174on-repaired and P174off demonstrating transcriptional activity on
plates containing X-Gal with and without 100 ng/ml of BlpCR6 in strains with the full-length blpA ORF and dependence on exogenous BlpC in the strains with
a disrupted blpA ORF. (D) P133 induces blp transcription in the P174off strain when X-Gal is included in the overlay. (E) BlpC6A secretion conﬁrmed in strain
19Ablp133blpC6A using reporter strain P1802 and X-Gal in the overlay. 19Ablp133CR6 was unable to inhibit 19Ablp174 (F), while 19Ablp133C6A showed clear
inhibition against 19Ablp174 in the overlay (G). (H) Inhibitory activity was noted against P537 in P174onlanC but not in P174offlanC.
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derivative with a deletion in its BIR (19ABIR; bacteriocin sensi-
tive) or the 19A strain containing the entire P174 blp locus (bac-
teriocin immune). Each strain was inoculated singly or in combi-
nation into the mouse nasopharynx, and colonization was
assessedbynasalwash.Allstrainscolonizedatsimilarlevelswhen
given alone (Fig. 3A). The 19Ablp133 bacteriocin producer strain
outcompeted 19ABIR but not 19Ablp174 (Fig. 3B), suggesting
that the blp-mediated competition and induced immunity ob-
served in plate overlay assays also occur on mucosal surfaces.
Characterization of the inhibitory proﬁle of 51 colonizing
andinvasiveisolatesfromSouthAfrica.Toverifythecorrelation
of an intact blpA with endogenous activity of the locus, we ex-
panded our study to include the remainder of the 51-member
strain collection to which P133 and P174 belong. This collection
was derived from strains compiled from ongoing surveillance
studies in South Africa (SA isolates) and includes colonizing and
invasive isolates of 15 distinct serotypes (see Tables S1 and S2 in
the supplemental material). Using agar overlay assays, we tested
each isolate against itself and the remaining isolates (Fig. 4A).
Three isolates (P140, P155, and P164) inhibited the majority of
otherstrainswithaspectrumsimilartothatofP133(Fig.4B).Two
isolates, P131 and P132, had inhibition limited to the blp deletion
strain P537 (Fig. 4B) (data not shown). The BIR of these strains
was sequenced, and putative bacteriocins were identiﬁed. P140
hadonlytheblpIJKcluster,whileP155andP164hadidenticalBIR
sequences and contained genes encoding BlpIJ followed by two
putative bacteriocin-like proteins not found in the existing se-
quence database. The BIR sequence of P132 contained only blpK.
Deletion and heterologous expression strains were created using
theblplocifromP140andP164toverifythedependenceoftheblp
locus on inhibitory activity in both isolates (Fig. 4B). The spectra
of inhibition of isolates P133 and P140 were identical and in-
cluded all but each other, P164, P155, and four “immune-only”
isolates, P130, P147, P170, and P174 (Fig. 4A and 4C). The fact
that P133 did not inhibit P140 or P164/P155 suggests that the
inhibitoryactivityofP133islargelyattributedtothesharedblpIJK
clusterratherthantheblpMNOclusterfoundonlyinP133.Unlike
P133 and P140, P164 and P155 were able to inhibit the growth of
the immune-only isolates (Fig. 4A).
RFLPmappingoftheBIRintheSAisolatecollectiondemon-
strating heterogeneity. In order to study the heterogeneity of the
BIRintheSAisolatecollection,weanalyzedthisregionfromeach
isolatebyrestrictionfragmentlengthpolymorphism(RFLP)anal-
ysis. The BIR from each isolate was ampliﬁed by PCR using con-
served sequence primers within blpA and blpY. PCR products
wereobtainedin49/51isolates.AttemptstoamplifytheBIRofthe
two remaining isolates using different primers in blpA and blpY
FIG 3 The 19A strain expressing the P133 blp locus outcompetes 19ABIR
but not the 19A strain expressing the P174 blp locus during mouse nasopha-
ryngeal colonization. (A) Mice were singly colonized with 19ABIR,
19Ablp133CR6,o r1 9 A blp174, and colonization density was determined at day 4
postinoculation. Colonization levels were not signiﬁcantly different, as deter-
mined by Mann-Whitney analysis. A dotted line indicates the limit of detec-
tion. (B) Competitive index of 19ABIR or 19Ablp174 when cocolonized with
19Ablp133CR6. The horizontal line represents the mean for each group. The
competitiveindex(CI)wascalculatedforeachmouse,andPvaluescomparing
CI values in each group were determined by Mann-Whitney analysis. The
dotted line denotes equivalent colonization at a competitive index of 1.
FIG 4 Summary of inhibitory and immunity proﬁles of the South African
isolates.(A)Tablesummarizingtheresultsofoverlaysofeachofthe51isolates
andP537againsteachother.0denotesnoinhibition,anddenotesinhibition
of the overlay. (B) Overlay assays demonstrating the inhibitory activity of
selected South African isolates and their derivatives demonstrating that the
locus is necessary and sufﬁcient for inhibitory activity. (C) P133 spiked into a
plate fails to inhibit the growth of P130, P147, P170, and P174 but not TIGR4.
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digestedseparatelywithAseIorMfeItocreatearestrictionmapof
theregion(Table1;seeFig.S1inthesupplementalmaterial)(data
not shown). The resultant banding patterns were compared with
predicted patterns from the 15 known distinct BIR regions in the
sequencedatabaseandthenewlysequencedbroadlyactiveisolates
(seeTableS3inthesupplementalmaterial)(2,8–13).Ifanisolate
had different restriction patterns from any other isolate in one of
the two digests, it was assigned to a separate group. Using this
strategy,wewereabletodividethe51isolatesinto17groups.Ten
of these could be assigned to known BIR sequences in the data-
base, based on their restriction patterns (Table 1). P131 and P132
had identical BIR sequences by RFLP analysis. The four immune-
only isolates had identical RFLP patterns to P133, suggesting that
their bacteriocin and immunity contents were identical (see
Fig. S1 in the supplemental material).
Determination of the blpC type in the SA isolate collection.
The blpC gene was sequenced in all isolates (Table 1; see Table S2
in the supplemental material) and was found to be largely un-
linked to BIR group. The largest BIR group had representatives
from three of the four known pherotypes. The variability of the
blpC type suggests that the pherotype is under selective pressure
withnewpherotypesacquiredbyhorizontalgenetransfer,similar
to what has been observed with the homologous competence-
stimulating peptide locus (14). P155 had a novel blpC sequence
(see Table S4 in the supplemental material) that was clearly dis-
tinct from the four known pherotypes and notably from the
blpC164 type produced by P164 which carries an identical BIR
sequence.P133andP140sharethesameblpCR6pheromoneasthe
four immune-only isolates, suggesting that, like P174, the
immune-only strains may have disrupted blpA genes. P164 and
P155,whichretaintheabilitytoinhibittheimmune-onlyisolates,
express non-blpCR6 pheromones. These observations, in combi-
nation with the distinct inhibitory proﬁle of pherotype switch
strains,conﬁrmthatpherotypeiscriticalindictatingtheoutcome
of producer-cheater interactions. Matching pheromone response
systems, if combined with appropriate immunity proteins, will
resultinprotectionfrombacteriocin-mediatedinhibitionevenin
transporter-defective strains.
Construction of type 1, 2, and 3 reporter strains. To address
the possibility that more isolates had active blp loci but lacked
inhibitioninoverlayassays,wedesignedaseriesofreporterstrains
to evaluate for pheromone secretion. We theorized that phero-
monesecretioncouldserveasacorrelateforbacteriocinsecretion
because the same machinery is required for the secretion of both
peptides, and detection of pheromone secretion does not require
knowledge of the target organisms. To assess whether the isolate
collectioncontainedisolatesthatwerecapableofsecretingpeptide
pheromone,weconstructedthreestrainswithlacZreportergenes
fused to the BIR promoter in strains responsive to BlpC types
P164, R6, and 6A. No reporter could be constructed against
BlpCT4 because no active isolates with this type could be identi-
ﬁed. The blpA gene was disrupted in each reporter so that strains
would respond only to exogenously added BlpC. The absence of
crossstimulationofthereporterconstructsbynoncognatephero-
types was veriﬁed using known pheromone secretors (Fig. 5A to
C). The SA isolate collection was tested in reporter overlay assays
with each of the three reporter strains. Isolates secreting phero-
mone were identiﬁed by a zone of blue surrounding the spiked
growth. Using this strategy, we were able to identify 13 additional
noninhibitory isolates that were actively secreting peptide phero-
mone (Fig. 5).
blpA sequence variation in active and inactive isolates. To
verify the correlation of pheromone secretion with an intact blpA
ORF, we sequenced the region surrounding the repeats in all iso-
lates. Twenty-ﬁve of 51 isolates lacked the 4-bp repeat consistent
withanintactblpAORF.These25isolatesincludedall6inhibitory
isolatesandeachofthe13pheromone-secretingisolates.Eighteen
of51isolateshadablpAgenewiththe4-bprepeat,includingP174
and the three additional immune-only isolates. Like P174, the
remaining immune isolates lacked the ability to secrete bacterio-
cinorpheromonebutcouldrespondtoexogenousBlpCR6,result-
TABLE 1 BIR group assignment of the South African isolates.
Group no. (pattern type)a No. of isolates RFLP match to GSSb or known BIR sequence Serotype(s) represented blpC type(s)
1 12 2306 6B, 9N, 15B, 18A, 23A, 23F P164, R6, 6A
2* 6 TIGR4, P133 6A, 6B, 23F R6, 6A
3 5 1031 6A, 11A, 22 P164, R6, T4
4 4 19F 6A
5* 3 P132 23F, 29 6A
6 4 TCH8431 19F, 45 P164, 6A
7 2 ATCC 700669 6A, 14 T4
8 2 22 6A
9* 2 P164, P155 6B, 45 P164,P155
10 2 CDC 1873 19A, 23F 6A, T4
11 1 SP3BS71 3 R6
12* 1 P140 35B R6
13 1 6A R6
14 1 14BS69 14 6A
15 1 3 6A
16 1 19F 6A
17 1 35 6A
NAc 2 15B, 19F 6A
a Groups with an asterisk have members with inhibitory activity.
b GSS, genome sequenced strains represented by GenBank designations. Isolate numbers preceded by “P” represent strains described in this study with available BIR sequence
information.
c NA, not ampliﬁed.
Pneumococcal Bacteriocin Producers and Cheaters
September/October 2011 Volume 2 Issue 5 e00179-11
® mbio.asm.org 5ing in bacteriocin-speciﬁc immunity. The blpA gene could not be
ampliﬁedin8isolates,suggestingthepresenceofeithersigniﬁcant
sequence variation in the primer binding site or a large deletion.
blpA sequence alignment and phylogenetic analysis. To ad-
dress the question of whether the repeat insertion or deletion of
the4-bpsequenceislikelytooccurwithinaclonalpopulation,we
performed phylogenetic analysis of the 500 bp of the blpA se-
quence which ﬂank the repeat region and compared this with the
3=-most 500 bp of the gene. To remove the variation in repeat
sequence from the analysis, the 4-bp repeat was removed from all
repeat-containing genes. All available full-length blpA sequences
from our data and the database were used for this analysis (2,
8–13). A neighbor-joining phylogenetic tree was created for both
regions (Fig. 6A to C). The tree derived from the region ﬂanking
the repeats demonstrated clustering of repeat-containing strains.
This clustering became much less apparent when the 3= regions
were analyzed and when the blpC type was considered. This ﬁnd-
ing suggests that acquisition of repeats is a result of homologous
recombination with DNA from a repeat-containing strain rather
than as a result of variation within a single clonal population.
DISCUSSION
Bacteriocin production provides organisms with a means to out-
compete sensitive members of the surrounding ﬂora. We were
interestedintheobservationthatmanytestedclinicalisolateslack
any appreciable inhibitory activity despite containing an appar-
entlyintactblplocus(1,2).Ourcurrentstudyofanisolatecollec-
tion from an area with a high rate of colonization and disease,
where the bacterial isolates would be expected to have the most
competitive phenotypes, allowed us to dissect the various strate-
gies that pneumococci have adapted to take advantage of bacteri-
ocin production and immunity. In studying this collection, we
haveidentiﬁedacommoncheaterphenotype,wheresomestrains
bypass costly endogenous pheromone and bacteriocin secretion
whilemaintainingtheabilitytoexpressimmunityinthepresence
of signal pheromone produced by surrounding strains. We have
identiﬁed that the mechanism for this cheater phenotype occurs
via a 4-bp insertion in the gene encoding the transporter BlpA,
which is responsible for pheromone and bacteriocin secretion.
It is clear that the 4-bp insertion is present in a signiﬁcant
numberofpneumococcalstrains.Acompilationofthe28unique
fullysequencedblplocifromthedatabasedemonstratesthat11/28
(39%)wouldbepredictedtoencodeafunctionalfull-lengthBlpA
protein,12/28(43%)havethe4-bpframeshiftrepeatinblpA,and
the remaining 5/28 (18%) have other frameshift mutations or
large deletions in blpA. BlpA sequencing and phenotypic analysis
have demonstrated that our South African isolate collection
closelymimicsthesenumbers:26/51(51%)isolateshavethe4-bp
repeat or a deletion in blpA, while 25/51 (49%) lack the 4-bp
repeat(althoughthepresenceofmutations3=totherepeatregion
was not assessed in all cases).
Phylogenetic analysis of blpA sequences demonstrates tight
clusteringofrepeat-containingstrainsonlywhensequencesﬂank-
ing the repeat region are analyzed. This suggests that repeats are
gained and lost via horizontal transfer by homologous recombi-
nation with foreign DNA rather than via an endogenous source
such as slipped-strand mispairing or intragenetic recombination.
Repeat-containing blpA genes are found in strains in 4/6 major
pneumococcal lineages deﬁned by Donati et al. (15), and intact
blpA genes are found in 5/6 lineages, further supporting the hy-
pothesis that repeat acquisition and loss are a dynamic process
ratherthantheresultofexpansionofasingleancestralstrain.This
is likely facilitated by the natural competence of this organism,
which may allow individual isolates to sample different strategies
forsurvival.Althoughotherframeshiftmutationscanbefoundin
the blpA gene, the 4-bp repeat is the predominant strategy for
inactivation. Why this mutation has been selected for widespread
disseminationoverothersisnotknown.Althoughtheoretical,itis
possiblethatthetruncatedN-terminalportionofBlpAthatresults
from the frameshift plays a role in bacterial ﬁtness.
It should be noted that, in the article by Lux et al., inhibitory
activity attributable to the blp locus was noted in strains with
frameshifted BlpA proteins (2). We have analyzed our isolate col-
lection using identical assay conditions and have failed to note
inhibitory activity or pheromone secretion in any isolate with an
interrupted BlpA protein (data not shown).
It is unclear what selects for production over immunity only
(cheaters) in pneumococcal populations. Populations of inhibi-
tory,immune,andsensitivestrainsprobablyexistinconstantﬂux,
as has been described for colicin-producing populations due to a
balance of energetic cost to competitive advantage via direct
growth inhibition (16). The energetic cost of bacteriocin and
pheromone secretion and the potential for activation of the locus
even in the absence of competitors likely drive the selection of
cheater strains that beneﬁt from their neighbor’s bacteriocin pro-
duction. Cheater strains run the risk of elimination if they en-
counter a producing strain that secretes a pheromone that they
cannot sense. We have been unable to test this hypothesis experi-
mentallybylookingatgrowthkineticsorcompetitionbecausethe
locus is only spontaneously activated when bacteria are grown on
solid media. The fact that the entire locus, including the two-
component regulatory genes, is maintained in every available se-
quenced strain, including those that lack the capacity for self-
regulation, argues that the ability to respond to exogenous
pheromone is an important survival strategy.
FIG5 Representative isolates with pheromone secretion detected in overlays
with reporter strains speciﬁc for BlpC164 (A), BlpCR6 (B), or BlpC6A (C). Iso-
lateswereinoculatedintoTSAplates6hbeforeasoftagaroverlaywasapplied
containingtheBlpC-speciﬁcreporteroverlaystrainandX-Gal.Thespeciﬁcity
ofthereportersisdemonstratedintheﬁrstpanelofeachrow.Arrowsdemon-
stratewheresecretingstrainsofthedifferentpherotypewerespiked.Inthecase
of P133, a zone of inhibition can be seen inside the larger zone of pheromone
secretion.
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quence, and BIR can vary independently of each other despite a
separation of less than 4 kb on the genome. This suggests that
separate selective pressures drive the diversity of BlpC type, BIR
content, and activation status via blpA reading frame alterations.
The observation that many strains exist in a transporter-deﬁcient
state, which only allows for immunity when bacteria are activated
by a neighbor secreting their cognate BlpC type, may explain the
selective pressure on pherotype. Strains that have an active blp
locuslikelybeneﬁtfromvariabilityintheirBIRcontentbyaltering
their arsenal of bacteriocin peptides, while the requirement for
bacteriocin-speciﬁc immunity may drive variability of the BIR
even in inactive strains. The striking variability in this locus pro-
vides us with a snapshot view of the effects of the pressure exerted
on this organism by other members of the nasopharyngeal ﬂora.
MATERIALS AND METHODS
Thecollectionofcolonizingandinvasivediseaseisolateswasapprovedby
theHumanResearchEthicsCommittee,UniversityoftheWitwatersrand,
South Africa. Written informed consent was obtained from colonization
studyparticipantsortheirlegalguardians.Invasiveisolateswereacquired
as part of routine clinical care, and no patient information was recorded.
All animal studies were carried out in strict accordance with the recom-
mendationsintheGuidefortheCareandUseofLaboratoryAnimalsofthe
National Institutes of Health (17). The protocol was approved by the
CommitteeontheUseandCareofAnimalsattheUniversityofMichigan.
Bacterialstrains,serotyping,andgrowthconditions.Pneumococcal
isolates were derived from ongoing colonization studies or invasive dis-
ease surveillance in South Africa and were derived from individuals who
had colonization or disease with one or more serotypes (see Table S1 in
the supplemental material). Pneumococci were serotyped by the Quel-
lung method using speciﬁc antisera, including the new 6C antiserum
FIG 6 Phylogenetic tree of blpA sequences in genome sequenced strains and South African isolates. (A) Phylogenetic tree of 500 bp of blpA sequence ﬂanking
the repeat region determined by the neighbor-joining method (25) after removal of the repeat sequence. Partitions reproduced in less than 25% of bootstrap
replicates are collapsed. Percentages of replicate trees in which taxa cluster together in the bootstrap test are shown next to branches. Repeat-containing strains
are designated by circles; isolates without the repeat are designated by squares. Pherotypes are designated by colors, as follows: P164, blue; R6, red; 6A, green;
TIGR4, black; and P155, yellow. (B) Phylogenetic tree of 500 bp at the 3= end of the blpA open reading frame analyzed as in panel A. (C) Representation of the
regions of blpA analyzed in panels A and B drawn to scale. The small arrow designates the location of the repeat sequence.
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grownat37°CinTodd-Hewittmediumwith0.5%yeastextract(THY)or
on tryptic soy agar (TSA) plates supplemented with 4,741 U of catalase
(Worthington, Lakewood, NJ) or 5% sheep blood (SBA). Plates contain-
ing pneumococci were grown in 5% CO2. Escherichia coli was grown in
Luria broth (LB) or LB agar with appropriate antibiotics. The following
antibiotic concentrations were used: for S. pneumoniae, 500 g/ml kana-
mycin, 200 g/ml streptomycin, 2 g/ml chloramphenicol, 1 g/ml
erythromycin, and 100 g/ml spectinomycin; and for E. coli,5 0g/ml
kanamycin, 20 g/ml chloramphenicol, 100 g/ml erythromycin, and
100 g/ml spectinomycin.
Overlay assays. Strains to be tested for inhibitory activity were grown
up initially on SBA plates overnight. Colonies were scraped from SBA
plates and inserted into TSA plates with catalase using a 48-pin replicator
or pipette tip. Growth was allowed to continue for6ha t37°C before the
overlay was applied. Overlay strains were grown to an optical density at
620 nm (OD620) of 0.3 to 0.5 in THY medium at 37°C. Two hundred
microliters of broth culture was added to 7 ml of molten TSA containing
0.5%agarandcatalaseandquicklyappliedtothetopoftheplatecontain-
ing the pregrown isolates. Plates were incubated overnight at 37°C before
being examined for zones of clearing. Activity overlay assays were per-
formed in an identical manner, except 50 l of X-Gal at 40 mg/ml was
added to the soft agar before pouring.
Construction of gain- and loss-of-function strains. Pneumococcal
transformationswereperformedaspreviouslydescribed(1,18).Serotype
19A replacements were performed by using the strain 19ABIR, which is
a streptomycin-resistant strain that contains an exchangeable Kanr rpsL
cassette encoding kanamycin resistance and streptomycin sensitivity (Ja-
nus cassette) (19) in place of the BIR. This strain was transformed with
genomic DNA from the inhibitory isolates P133, P140, and P164, and
transformants were isolated on TSA containing streptomycin. Each iso-
late was then back-transformed once, and the inhibitory phenotype was
conﬁrmedbyoverlayassay.Asimilarstrategywasusedtocreatethetrans-
formant containing the P133 BIR but the original type 3-producing up-
stream region. In this case, a type 6A strain carrying a Janus cassette in its
BIR was transformed with P133 genomic DNA. Streptomycin-resistant
colonies were screened for secretion of a type 3 blpC using reporter over-
lays with the type 3 reporter strain, P1802. Insertion of the P133 BIR was
conﬁrmedbyRFLPanalysisasdescribedbelow.Theentireblplocusfrom
this strain was then moved into the 19Ablp deletion strain, P690. blpRH
deletionswereintroducedintoisolatesP133,P140,andP164bytransfor-
mationwithgenomicDNAfromstrain6AblpRbyselectiononerythro-
mycin.MutationswereconﬁrmedbyPCRoftheblpRHregion.Thisstrat-
egycouldnotbeusedforP174becauseitwasresistanttoerythromycinat
baseline.Tomakeadeletioninthisisolate,whole-blp-locusdeletionswere
constructedbyjoiningthegenomicregionupstreamofblpTintheTIGR4
straintotheregionjustupstreamofblpXinthepCR2.1vectorbysequen-
tial cloning steps using primers 8 and 9 for the upstream portion and 10
and 11 for the downstream portion (see Table S5 in the supplemental
material). The two regions were separated by a unique ClaI site. The up-
stream region and downstream region were separated by digestion with
ClaI, and the Janus cassette with engineered ClaI sites generated with
primers6and7wasligatedtothisplasmid.Theresultingligationwasused
totransformstrainP376,andtheresultingtransformantswereselectedon
TSA with kanamycin. The resulting strain, P537, was exquisitely sensitive
to blp bacteriocin-mediated inhibition and was used for overlay assays to
demonstrate inhibitory activity. This mutation was moved into P174 us-
inggenomicDNA.Allconstructstobetestedinmiceweremovedintothe
type 19A background, which colonizes mice at high levels without evi-
dence of invasive disease. The streptomycin-resistant version of the type
19A strain, 19AstR, was transformed with genomic DNA from the blp
deletion strain P537 and selected on kanamycin. After a single back-
transformation to remove unlinked DNA, this strain was then trans-
formed with P174 genomic DNA to create 19Ablp174 for colonization
experiments.TransformantswereselectedonTSAcontainingstreptomy-
cin. RFLP analysis and overlay assays to assess inhibition and immunity
wereusedtoconﬁrmtransferoftheblpphenotypefromthedonorstrain.
Mouse competitive colonization. Six- to 7-week-old female BALB/c
mice were inoculated intranasally with 0.5  107 to 1.0  107 CFU/10 l
of bacteria resuspended in phosphate-buffered saline (PBS). Each strain
was given alone and in combination to ﬁve mice per group. Mice were
sacriﬁced by CO2 asphyxiation, and nasal washes were performed and
plated as previously described (1). Statistical analysis was performed by
Mann-Whitney analysis. Colonization by 19Ablp133CR6 in the 19ABIR-
19Ablp133CR6 dually colonized mice was determined by subtracting the
kanamycin-resistant colonies from the colony count on nonselective me-
dia. Because there was no selective marker to distinguish 19Ablp133CR6
from 19Ablp174, colonies were picked from nonselective plates and al-
lowedtogrowina96-wellplatecontainingTHYmediumfor6h.Ninety-
six colonies were chosen from each cocolonized mouse. Sixteen colonies
weretestedfromeachsinglycolonizedmouse.Theresultingcultureswere
replica plated on SBA plates, and overnight growth from these plates was
stabbed into TSA plates. Overlay assays with the sensitive strain P537 was
thenperformed.Colonieswithinhibitionwerescoredasby19Ablp133CR6;
those without inhibition were scored as 19Ablp174. Interpretability of the
results was veriﬁed by conﬁrming that 100% of organisms derived from
singlycolonizedanimalshadtheexpectedphenotype.Colonycountswere
obtained by multiplying the percentage of each strain determined by this
method by the total colony counts on nonselective media. A competitive
index was determined using the method of Monk et al. (20). P values for
the competitive index were determined by Mann-Whitney analysis.
Construction of P174on and P174off strains. The plasmid pE56 was
constructedbyamplifyingafragmentcontainingthe5=regionofblpAand
the divergent promoters of blpA and blpI plus 54 nucleotides (nt) of blpI
codingsequenceﬂankedbyNsiIandXbaIsitesoffoftheinhibitorystrain
P133,usingprimers3and4(seeTableS5).Thissequencewasclonedinto
NsiI-XbaI-cutreporterplasmidpEVP3(21)creatingatranscriptionalfu-
sion of the blpI promoter to the lacZ gene. This plasmid was made kana-
mycin resistant by inserting the kanamycin gene ampliﬁed with primers
14 and 15 into a unique EcoRI site in the plasmid. The resulting plasmid,
pE65, was transformed into P174, and transformants were selected on
TSA containing kanamycin. Because the insertion event would result in a
duplication of the inserted region, including the frameshift 4-bp repeat
sequence found in P174 but not P133, the intact version of blpA in each
transformant was determined by amplifying the blpA sequence in closest
proximity to the lacZ gene using primers 3 and 17 and then sequencing
this product using primer 16. Overlay assays evaluating for bacteriocin
production with these strains were performed with strains carrying a de-
letion in a novel non-blp bacteriocin locus (lanC) to remove the possible
impact of this locus on the results (data not shown).
RFLPanalysisoftheBIR,blpC,andblpAsequencing.TheBIRsofall
isolates were analyzed by PCR ampliﬁcation using conserved primers 1
and 2. PCR products were puriﬁed and digested with either AseI or MfeI.
The resulting digestion patterns were compared after ethidium bromide
(EtBr) staining with 1% agarose gels. Isolates with identical patterns in
both digests were assigned to the same group. The blpC sequence was
determined by sequencing the PCR fragment produced by ampliﬁcation
with primers 12 and 13. The blpA gene of selected isolates was sequenced
in its entirety after ampliﬁcation with primers 18 and 19. The repeat-
containing region of the remaining isolates was ampliﬁed and sequenced
using primers 3 and 16.
The BlpC type P164 and R6 pheromone reporter strains were con-
structed as follows. A fragment containing 700 bp upstream of the ﬁrst
bacteriocin gene, blpQ, in addition to the ﬁrst 43 nt of coding sequence,
was ampliﬁed from the type 6B strain P4 determined by sequencing to
carry a type P164 blpC gene, using primers 3 and 5. The fragment was
clonedintothereporterplasmidpEVP3asdescribedfortheconstruction
of pE56, creating plasmid pE57. This plasmid was transformed into the
type6BstrainandselectedonTSAplateswithchloramphenicol.Insertion
oftheplasmidintotheexpectedsiteintheblplocuswasconﬁrmedbyPCR
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genomicDNAfromthisstrainwasmovedintothelaboratorystrain,R6x,
which carries an R6 blpC gene. Transformants were selected on on TSA
withchloramphicol,andthecolonieswerescreenedforresponsivenessto
type P164 or type R6 synthetic peptides by plating on TSA plates supple-
mented with X-Gal and 100 ng/ml of synthetic peptide (Genscript, Pisca-
taway,NJ).Onecolonyofeachwaschosen,andtheblpCsequenceveriﬁed
by sequencing using primers 12 and 13. To remove the impact of endog-
enous BlpC secretion on these strains, the blpA gene was disrupted by
transforming strains with the plasmid pE49, which contains the inter-
rupted blpA gene from strain P1802, allelic exchange was veriﬁed using
primers 21 and 23. The type 6A reporter strain, P1802, was previously
constructed (7).
Construction of a phylogenetic tree of blpA nucleotide sequences
surrounding and distant from the repeat region. blpA sequences were
obtained from the publicly accessible databases and from the strains in
our collection in which the blpA gene was fully sequenced. Sequences in
the 500 bp ﬂanking the repeat region and a 500-bp fragment 933 bp away
were aligned and evaluated using MEGA 5 (22). The evolutionary history
was inferred using the neighbor-joining method (23). Bootstrap analysis
wasperformedon5,000replicates.Theevolutionarydistanceswerecom-
puted using the maximum composite likelihood method (24). All posi-
tions containing gaps and missing data were eliminated, including the
repeat sequence and a 27-nt duplicated sequence. Two genome sequence
strains with large deletions in the blpA gene were not included in the
analysis (Taiwan 19A and TCH8431/19A).
Nucleotide sequence accession number. Newly derived sequences
weresubmittedtoGenBankunderthefollowingaccessionnumbers:P133
BIR, HQ702850; P132 BIR, HQ676608; P140 BIR, HQ668083; P155 BIR,
HQ668085, and P164 BIR, HQ668084. The accession numbers of the
BlpA full sequence are as follows: P124, HQ690079; P131, HQ690080;
P132, HQ690081; P140, HQ690082; P141, HQ690083; P144, HQ690084;
P147, HQ690085; P155, HQ693884; P158, HQ693885; P162, HQ693886;
P163, HQ693887; P164, HQ693888; P173, HQ693889; P174, HQ693890;
and P155 BlpC, HQ668086.
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